Menu

Home / For Visitors / 2024 Exhibitor Product / Nanobody based Trispecific Antibody of T cell Engager

Nanobody based Trispecific Antibody of T cell Engager

Model: SOA101

Category: Pharmaceutical

Exhibitor: SHINE-ON BIOMEDICAL CO., LTD.

Booth No: N715

Characteristic

1. Dual ICIs leading in Asia: SOA101 targets dual immune checkpoints, PD-L1 and HLA-G, on cancer cells.
2. Low risk of CRS: Patented T cell engager enhances T-cell mediated anti-tumor ability in the tumor environment locally.
3. Nanobody with high affinity to the target: With unique sequence, exposed CDR3 region of SOA101 is stable and with high affinity to the targets.
4. Broad-Spectrum Anticancer Efficacy: SOA101 is potentially effective to lung cancer, breast cancer, ovarian cancer, oral cancer, brain cancer and other solid tumors.

Other Products

Products you may be interested in

Highest Rated Products

TOP